Koshida, T.; Gohda, T.; Sugimoto, T.; Asahara, T.; Asao, R.; Ohsawa, I.; Gotoh, H.; Murakoshi, M.; Suzuki, Y.; Yamashiro, Y.
Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease. Int. J. Mol. Sci. 2023, 24, 11456.
https://doi.org/10.3390/ijms241411456
AMA Style
Koshida T, Gohda T, Sugimoto T, Asahara T, Asao R, Ohsawa I, Gotoh H, Murakoshi M, Suzuki Y, Yamashiro Y.
Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease. International Journal of Molecular Sciences. 2023; 24(14):11456.
https://doi.org/10.3390/ijms241411456
Chicago/Turabian Style
Koshida, Takeo, Tomohito Gohda, Takuya Sugimoto, Takashi Asahara, Rin Asao, Isao Ohsawa, Hiromichi Gotoh, Maki Murakoshi, Yusuke Suzuki, and Yuichiro Yamashiro.
2023. "Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease" International Journal of Molecular Sciences 24, no. 14: 11456.
https://doi.org/10.3390/ijms241411456
APA Style
Koshida, T., Gohda, T., Sugimoto, T., Asahara, T., Asao, R., Ohsawa, I., Gotoh, H., Murakoshi, M., Suzuki, Y., & Yamashiro, Y.
(2023). Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease. International Journal of Molecular Sciences, 24(14), 11456.
https://doi.org/10.3390/ijms241411456